Evidence map›Paper›PMID 26899387›Full record

Trial reportTrials2016

Impact of preoperative Vitamin D3 administration on postoperative hypocalcaemia in patients undergoing total thyroidectomy (HypoCalViD): study protocol for a randomized controlled trial.

Stefanie Wolak, Mandy Scheunchen, Katharina Holzer, Mirjam Busch, Esra Trumpf, Andreas Zielke

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Stefanie WolakSana-Klinikum Offenbach, Chirurgische Klinik, Starkenburgring 66, 63069, Offenbach am Main, Germany. steffi.wolak@gmx.de.
Mandy ScheunchenUniversitätsklinikum der Goethe-Universität Frankfurt, Fachbereich Zahnmedizin, 60590, Frankfurt, Germany. mandy.scheunchen@gmail.com.
Katharina HolzerUniversitätsklinikum der Goethe-Universität Frankfurt, Klinik für Allgemein- und Viszeralchirurgie, 60590, Frankfurt, Germany. Katharina.holzer@kgu.de.
Mirjam BuschDiakonie-Klinikum Stuttgart, Klinik für Endokrine Chirurgie, Endokrines Zentrum Stuttgart, Rosenbergstrasse 38, 70176, Stuttgart, Germany. buschm@diak-stuttgart.de.
Esra TrumpfDiakonie-Klinikum Stuttgart, Klinik für Endokrine Chirurgie, Endokrines Zentrum Stuttgart, Rosenbergstrasse 38, 70176, Stuttgart, Germany. trumpf@diak-stuttgart.de.
Andreas ZielkeDiakonie-Klinikum Stuttgart, Klinik für Endokrine Chirurgie, Endokrines Zentrum Stuttgart, Rosenbergstrasse 38, 70176, Stuttgart, Germany. andreas.zielke@diak-stuttgart.de.
Diakonie-Klinikum Stuttgart · DEGoethe University Frankfurt · DESana Klinikum Offenbach · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTotal thyroidectomy is increasingly used as a surgical approach for many thyroid conditions. Subsequently, postoperative hypocalcaemia is observed with increasing frequency, often resulting in prolonged hospital stay, increased use of resources, reduced quality of life and delayed return to work. The administration of vitamin D is essential in the therapy of postoperative hypocalcaemia; calcitriol is most commonly used. What has not been examined so far is whether and how routine preoperative vitamin D prophylaxis using calcitriol can help to prevent postoperative hypocalcaemia. This study evaluates routine preoperative calcitriol prophylaxis for all patients who are to undergo a total thyroidectomy, compared with the current standard of post-treatment, i.e., selective vitamin D treatment for patients with postoperative hypocalcaemia. METHODS/

designThis clinical observational (minimal interventional clinical trial) trial is a multicentre, prospective, randomized superiority trial with an adaptive design. Datasets will be pseudonymized for analysis. Patients will be randomly allocated (1:1) to the intervention and the control groups. The only intervention is 0.5 μg calcitriol orally twice a day for 3 days prior to surgery. For the primary endpoint measure (number of patients with hypocalcaemia), hypocalcaemia is defined as serum calcium of less than 2.1 mmol/l on any day during the postoperative course; this measure will be analyzed using a Chi-square test comparing the two groups. Secondary endpoint measures, such as number of days to discharge, quality of life, and economic parameters will also be analyzed. DISCUSSION: By virtue of the direct comparison of clinically and economically relevant endpoints, the efficacy as well as efficiency of preoperative calcitriol prophylaxis of hypocalcaemia will be clarified. These results should be available 24 months after the first patient has been enrolled. The results will be used to inform a revised practice parameter guideline of whether or not to recommend preoperative calcitriol for all patients in whom total thyroidectomy is planned.

trial registrationDeutsches Register Klinischer Studien, DRKS00005615 (Feb.12.2016).

Indexed as

CalcitriolDietary SupplementsHypocalcemiaThyroid DiseasesThyroidectomyBiomarkersCalciumChi-Square DistributionDrug Administration ScheduleGermanyHumansPreoperative CareProspective StudiesResearch DesignTime FactorsTreatment OutcomeBiomarkersCalcitriolCalcium

Identifiers

PMID26899387
PMCPMC4761142
OpenAlexW2277526408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.